Unlabelled: Aim of the work was to examine the influence of HCV genotype on the clinical features of chronic hepatitis and cirrhosis.

Materials And Methods: Were examined 9.715 patients under treatment in hospital gastroenterological for the presence of hepatitis C virus. In 365 patients was found HCV RNA. At 210 patients was performed genotyping. Was performed a quantitative analysis of 193 patients. There were determined cytolytic syndrome (ALT, AST), cholestatic (alkaline phosphatase, bilirubin), the activity of GGT in the blood of patients by biochemical markers.

Results And Discussion: The frequency of virus infection, confirmed by PCR analysis of data from this group of patients was 3.7% (95% CI 3.3-4.1). Occurrence of genotypes of hepatitis C was for 1 genotype 61.4% (54.7-68.1, 95% CI) for the 2-th genotype--10.9% (6.7-15.2; 95% CI) and the third genotype--at 27.6% (21.5-33.7, 95% CI). Viral load was significantly higher (p < 0.05) at 3-m type of HCV and was amounted to 8.08 +/- 15.6 million IU, compared with patients with 1st and 2nd genotype: 4.5 +/- 11.3 and 3.7 +/- 10.3 MIU. Also among patients with genotype 3 HCV viral load was (more than 800 thousand IU/ml) significantly more frequent in 50% of patients, whereas among patients with genotype 1 HCV, such patients was 22% and from 2 th HCV genotype--26% (chi2 = 13.0, p = 0.001). Significantly more frequent among patients with viral load more than 2.5 million IU/l at men (Fisher's test p = 0.03), as men often had the third genotype of hepatitis C (p < 0.005). Genotype was not significantly affected the performance of cytolytic and cholestatic syndromes. In patients with low viral load (less than 800 thousand IU/ml) was significantly less pronounced cytolytic syndrome, ALT was significantly lower (p < 0.05), the AST activity of reliable statistical difference was noted. Also significantly under high viral load (more than 800 thousand IU/ml) was higher than the activity of GGT (p < 0.05).

Conclusions: Thus, our data showed that among the patients in our hospital were more prevalent third genotype of hepatitis C virus than among the population of the Russian Federation. Gender particular occurrence of the third genotype require further study to clarify the role of gender or other factors, concomitant increase in its prevalence. The presence of the third genotype of hepatitis C virus was accompanied by a high viral load, and probably an additional toxic effect on hepatocytes.

Download full-text PDF

Source

Publication Analysis

Top Keywords

viral load
28
hepatitis virus
16
third genotype
16
patients
14
load 800
12
800 iu/ml
12
genotype hepatitis
12
genotype
11
cytolytic syndrome
8
syndrome alt
8

Similar Publications

Despite the successful rollout of antiretroviral therapy (ART) and positive ART outcomes in the Kingdom of Eswatini, adolescents still present poor ART outcomes including low viral load suppression and suboptimal ART adherence. The aim of the study was to explore the perceptions of adolescents living with HIV (ALHIV) on the barriers and facilitators to ART adherence in Eswatini. We conducted a qualitative study using in-depth interviews among 29 ALHIV and on ART in Eswatini in December 2023.

View Article and Find Full Text PDF

Magnitude of Depression and Associated Factors in Women Living With HIV in Northwest, Ethiopia: Mediation Analysis.

AIDS Res Treat

January 2025

Department of Health Promotion and Behavioral Sciences, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Depression in women living with HIV (WLWHIV), is one of the most common public health concerns worldwide. Depression has a negative impact on antiretroviral therapy (ART) adherence, quality of life, poor HIV treatment outcomes, and mortality. However, there is a paucity of evidence in low-income countries such as Ethiopia in WLWHIV.

View Article and Find Full Text PDF

Highly active antiretroviral therapy (HAART) is imperative in managing human immunodeficiency virus (HIV) infections. HAART aims to inhibit viral replication and improve immunity. Antiretroviral therapy has led to significant improvement in CD4-T cell counts and reductions in viral load, leading to improved overall immune function, increased survival, and decreased frequency of opportunistic infections.

View Article and Find Full Text PDF

Metalloparticle-Engineered Pickering Emulsion Displaying AAV-Vectored Vaccine for Enhancing Antigen Expression and Immunogenicity Against Pathogens.

Adv Mater

January 2025

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.

Recombinant adeno-associated viruses (rAAVs) have emerged as promising vaccine vectors due to their enduring efficacy with a single dose. However, insufficient cellular immune responses and the random and non-specific distribution of AAVs post-injection may hinder the development of AAV vaccines. Here, a novel Pickering emulsion platform stabilized by biomineralized manganese nanoparticles and aluminum hydroxide, which can rapidly and efficiently load AAVs, is reported.

View Article and Find Full Text PDF

Green seaweeds, which make up a major population of total seaweed worldwide, possess various therapeutic properties. The aim of the study directed at isolating a (1 → 4) linked sulfated rhamno xyloglucuronan, designated as UFP-2, from the edible green seaweed Ulva fasciata Delile, and to evaluate its efficacy in modulating immune responses and inhibiting SARS-CoV-2 (Delta variant) infection. Anti-inflammatory potential of UFP-2 was demonstrated through the regulation of key cytokines involved in inflammatory responses triggered by viral infections, including interferons (IFN-α/γ), interleukin (IL-1β/12/33), and tumor necrosis factor (TNF-α).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!